CelLBxHealth

The team is excited to be attending #SABCS25 in San Antonio next week! Visit Booth 1327 to explore new functional CTC assay data designed to support target validation and enhanced patient selection. Book your 1:1 meeting with our team: cellbxhealth.com/event/san-anto… #CelLBxHealth

We are excited to welcome Atsushi Tsunomura, Kenroh Wakasugi, Takashi Sawashima, Tomoya Ono and Masaaki Kaneko from Yamato Scientific Co, our Japanese distributor, to CelLBxHealth HQ for two days of intensive product training. Find your nearest supplier: cellbxhealth.com/contact-us/

Latest study sheds light on how genomic profiling of circulating tumour cells (CTCs) can enhance prognostic assessment in metastatic colorectal cancer (mCRC). Read the full paper here: #Sec22" target="_blank" rel="nofollow noopener">link.springer.com/article/10.100… #CelLBxHealth #LiquidBiopsy #CancerResearch #CTCs

Elevate your workflow and capture every detail this season with our Portrait®+ CTC Staining Kit and CellKeep™ Slides — now available with exclusive special discounts if ordered prior to 19 December, 2025! Contact us today to find out more: cellbxhealth.com/contact-us/ #CelLBxHealth

New data in Glioblastoma (GBM) published! At #SNO2025 in Hawaii Cristina Caccioli presented new findings on how liquid biopsy offers a minimally invasive approach to monitor cancer progression through blood-based biomarkers. Access our posters in full: cellbxhealth.com/resources/post…

We are thrilled to be a part of #SNO2025 this year, meeting researchers and clinicians from all over the world! Visit our booth 210 and find out how our Parsortix® system can support you in profiling of CTCs for targeted patient selection into clinical trials. #CelLBxHealth #CTCs

This November, we are proudly standing with survivors, caregivers, and families impacted by lung cancer for Lung Cancer Awareness month! Join us in spreading the word and raising awareness of the challenges that come from a diagnosis of lung cancer. #CelLBxHealth #LungCancer

Are you heading to #SNO2025 in Hawaii this week? Don't miss the poster and networking session on November, 21st at 11.30am. Crisitna Ciccioli, Head of Assay Development will present her poster. Secure your meeting with our team: cellbxhealth.com/event/world-fe… #CelLBxHealth #SNO2025

"Novel strategies for CTC analysis in GBM" webinar is now available on-demand here: lnkd.in/eVCWTJ6X View the full recording and learn from Dr. Francesca Lessi and Dr. Mariacristina Ciccioli.

Meet the #CelLBxHealth team at #SNO2025, November 19-23 in Honolulu and discover how the Parsortix® system successfully isolates Glioblastoma CTCs and CTC clusters. We are exhibiting at Booth 210. Secure your 1:1 meeting with our team ahead of the event: cellbxhealth.com/event/world-fe…

Special Seasonal Promotion – Limited Time Only! Order the Parsortix® system TODAY and discover how our patented CTC enrichment technology can transform your liquid biopsy research. Don’t miss out on special discounts on all our products - contact us now: cellbxhealth.com/contact-us/

New independent expert consensus published: predicts integration of CTC testing into routine clinical practice within 5 years and identified the Parsortix® platform as the most promising next generation technology for clinical applications. Read here: lnkd.in/e87dDmWH

ANGLE plc is now CelLBxHealth plc. The new name reflects the Company's sharpened focus on 'CTC intelligence', the provision of high-value CTC-based precision diagnostic testing for the pharmaceutical services sector and the clinical diagnostics market. cellbxhealth.com

We are just back from #WorldADC in San Diego! Our CCO, @BrettSwansiger, delivered a powerful presentation on “Circulating Tumor Cells: a Powerful Tool for Real-Time Target Assessment & Strategic Development of ADCs in Cancer Therapy”. Lean more: cellbxhealth.com/laboratory-ser… #CTCs

We were honoured to take part in this year’s #ISLB25 Annual Congress of Liquid Biopsy in Orlando, USA! @Brett Swansiger and @Neil Darroch showcased our proprietary Parsortix® system, the optimal solution for capturing and harvesting circulating tumour cells (CTCs).

Are you travelling to San Diego next week? Don’t miss ANGLE’s presentation at #WorldADC on Circulating Tumor Cells: a Powerful Tool for Real-Time Target Assessment & Strategic Development of ADCs in Cancer Therapy by our Senior Director, Head of R&D, Anne-Sophie Pailhes-Jimenez.

The team is excited to be attending #WorldADC in San Diego next week! Visit our Booth 47 to see new Parsortix® CTCs functional assay data for target validation and patient selection for your ADC development programme. Book your 1:1 meeting with our team: angleplc.com/event/world-ad…

Join the #ANGLE team at #ISLB25, November 1-3 to discuss how CTC-DNA and ctDNA can help enhance your research. The ANGLE team will be exhibiting at the ISLB Annual Congress at Booth 107. Secure your 1:1 meeting with our team ahead of the event: angleplc.com/event/islb-7th…

Did you miss our exciting new webinar? The full recording of “Novel strategies for circulating tumor cell analysis in glioblastoma” is now available: labroots.com/ms/webinar/nov… #ANGLEplc #glioblastoma #CancerResearch #CTCs For Research Use Only. Not for Use in Diagnostic Procedures.

#ANGLE R&D team published promising data using #HER2 assays with circulating tumour cells (CTCs) in breast cancer, demonstrating innovative techniques like (IF) staining and (FISH). Discover the latest data here: angleplc.com/resources/publ… #ANGLEplc #LiquidBiopsy #BreastCancer